Allianz Asset Management
VNDA icon

Allianz Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Allianz Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-97,400
Closed -$642K – 2274
2023
Q2 		$642K Buy
+97,400
New +$624K ﹤0.01% 1670
2022
Q1 		– Sell
-28,194
Closed -$442K – 2674
2021
Q4 		$442K Sell
28,194
-1
-0% -$17 ﹤0.01% 2251
2021
Q3 		$484K Sell
28,195
-13,946
-33% -$244K ﹤0.01% 2247
2021
Q2 		$907K Buy
+42,141
New +$754K ﹤0.01% 1779
2020
Q2 		– Sell
-55,833
Closed -$578K – 2561
2020
Q1 		$578K Sell
55,833
-74,199
-57% -$920K ﹤0.01% 1999
2019
Q4 		$2.13M Buy
130,032
+73,251
+129% +$1.11M ﹤0.01% 1837
2019
Q3 		$754K Sell
56,781
-83,591
-60% -$1.16M ﹤0.01% 2231
2019
Q2 		$1.98M Sell
140,372
-1,687
-1% -$26.8K ﹤0.01% 1890
2019
Q1 		$2.61M Sell
142,059
-829
-0.6% -$18.9K ﹤0.01% 1746
2018
Q4 		$3.73M Sell
142,888
-5,475
-4% -$129K ﹤0.01% 1528
2018
Q3 		$3.4M Buy
148,363
+12,903
+10% +$263K ﹤0.01% 1731
2018
Q2 		$2.58M Sell
135,460
-758
-0.6% -$12.7K ﹤0.01% 1828
2018
Q1 		$2.29M Buy
136,218
+3,903
+3% +$65.3K ﹤0.01% 1862
2017
Q4 		$2.01M Sell
132,315
-1,507
-1% -$22.4K ﹤0.01% 2012
2017
Q3 		$2.4M Sell
133,822
-1,115
-0.8% -$18.7K ﹤0.01% 1945
2017
Q2 		$2.2M Buy
134,937
+5,451
+4% +$78.6K ﹤0.01% 1949
2017
Q1 		$1.81M Sell
129,486
-10,594
-8% -$151K ﹤0.01% 2033
2016
Q4 		$2.23M Sell
140,080
-12,384
-8% -$199K ﹤0.01% 1940
2016
Q3 		$2.54M Buy
152,464
+104,324
+217% +$1.4M ﹤0.01% 1897
2016
Q2 		$539K Buy
+48,140
New +$466K ﹤0.01% 2298
2015
Q2 		– Sell
-23,230
Closed -$216K – 2511
2015
Q1 		$216K Buy
+23,230
New +$262K ﹤0.01% 2188

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allianz Asset Management's VNDA Position: Q3 2023 in Review

Allianz Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 97,400 shares — an estimated $642K sold.

Allianz Asset Management first reported a position in VNDA in Q1 2015 and held it in 21 quarters. The position peaked at $3.73M in Q4 2018. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

  • Allianz Asset Management reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Allianz Asset Management sold 97,400 Vanda Pharmaceuticals shares in Q3 2023, an estimated $642K.
  • Allianz Asset Management first reported a position in Vanda Pharmaceuticals in Q1 2015 and held it in 21 quarters.
  • Allianz Asset Management's Vanda Pharmaceuticals position peaked at $3.73M in Q4 2018.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Allianz Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.